Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term fundamentals.
Bristol Myers Squibb Stock Earns 83 RS Rating On Thursday, Bristol Myers Squibb stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.
Novartis Earns Near-Best Overall Rating As Profit Growth Climbs Novartis ranks No. 1 among in the 33-stock Medical-Ethical Drugs industry group. Novartis got a Composite Rating upgrade to 96 on Wednesday.
Novartis Earnings Surprised The Street; Still Going Strong Despite Market Correction Highly ranked Novartis is forming the right side of a long cup base with a buy point of 120.92. And it's literally running higher.
Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade On Friday, Bristol Myers Squibb stock earned an upgrade to its Relative Strength (RS) Rating, from 62 to 79.
Earnings Scheduled For February 7, 2024 Companies Reporting Before The Bell • Madison Square Garden (
NYSE:MSGE ) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Bristol-Myers Squibb's Profits, Stock Price Kick Into High Gear A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?
How To Invest In Small Cap Value Stocks In 2024 Many of the small caps have gotten cheap. If you want to find value stocks, the small caps is the place to look.
PAHC Stock Earnings: Phibro Animal Health Beats EPS, Beats Revenue for Q3 2024 PAHC stock results show that Phibro Animal Health beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
